Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration ...

Galantamine was first approved by the US Food and Drug Administration (FDA) in 2001 for treating Alzheimer's and vascular dementia. "This has the potential to significantly improve the lives of ...